Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Omega Bioservices offers next generation sequencing (NGS), Sanger sequencing, DNA/RNA extraction, library preparation, fragment analysis, genotyping, qPCR, microarray analysis and bioinformatics services to academic institutions, biotechnology companies, government agencies and pharmaceutical clients. They provide GLP-compliant DNA sequencing with rapid turnaround times and international order capability. The division is part of Omega Bio-Tek's broader expertise in nucleic acid isolation technologies. As a division of Omega Bio-Tek, Omega Bioservices utilizes advanced molecular biology techniques, including NGS with Illumina HiSeq2500 instruments and Sanger sequencing with Applied Biosystems platforms. They also offer specialized exon sequencing/mutation discovery workflows, from sample extraction to mutation mapping with bioinformatics support. All services adhere to GLP/CLIA guidelines and can include same-day turnaround for an additional cost, with international orders accepted.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Omega Bioservices.